Bioventus (NYSE:BVS) Announces Quarterly Earnings Results

Bioventus (NYSE:BVS – Get Rating) announced its earnings results on Tuesday. The company reported $0.04 EPS for the quarter, missing analysts’ consensus estimates of $0.05 by ($0.01), MarketWatch Earnings reports. Bioventus had a net margin of 2.67% and a return on equity of 21.93%. During the same quarter in the previous year, the firm earned […]

Related Keywords

United States ,Canada ,John Nosenzo ,Craig Hallum ,Anthony Dadamio ,Morgan Stanley ,Securities Exchange Commission ,Zacks Investment Research ,York Mellon Corp ,Cubist Systematic Strategies ,Goldman Sachs Group ,Citadel Advisors ,Bioventus Inc ,Royal Bank ,Get Rating ,Marketwatch Earnings ,Exchange Commission ,Systematic Strategies ,New York Mellon Corp ,Investment Research ,Bioventus ,Nyse Bvs ,Cbvs ,Medical ,Earnings ,